More Business Wire
View Older Stories View Newer Stories-
A. Menarini Diagnostics and Nucleix Announce a Strategic Partnership for a Non-Invasive Bladder Cancer Test in Europe
-
Kosmos Energy Announces Launch of Senior Notes Offering
-
Kosmos Energy Ltd. Announces Cash Tender Offers for up to $400 Million Principal Amount of 7.125% Senior Notes Due 2026 and up to $100 Million Aggregate Principal Amount of 7.750% Senior Notes Due 202
-
FPT Expands Nordic Reach with New Office in Sweden
-
ArcanaBio Secures Funding from BioInnovation Institute to Revolutionize Healthcare with new Ultra-Rapid Liquid Biopsy Technology
-
AHF: Equity for Africa in Pandemic Agreement Talks
-
Saint-Denis Hospital Center in France Implements Masimo SafetyNet® Telemonitoring to Facilitate Early Discharge of Premature Newborns from the Hospital
-
Ikonisys Announces the Launch of Ikoniscope Max in Europe at the 36th European Congress of Pathology in Florence
-
Epsilogen Completes £12.5 Million Series B Financing Expansion
-
Andrea Bozzi, Charles Andrez and Charles-Henri Filippi Join Evercore’s Paris Office
-
Juniper Research: Consumer A2A Payments - 186 Billion Transactions Globally by 2029
-
SynFutures Partners with Orbit Markets to Launch Innovative Protection Against Impermanent Loss
-
Poxel Reports Revenue for the Second Quarter and First Half 2024 and Provides Corporate Update
-
BeiGene Highlights TEVIMBRA® Data in Lung and Gastrointestinal Cancers at ESMO 2024
-
BW LPG Limited – Ex dividend USD 0.58 on the Oslo Stock Exchange today
-
Innate Pharma SA: Monalizumab Data From NeoCOAST-2 Phase 2 Study in Early-Stage NSCLC Presented at the WCLC 2024
-
Serra Automotive Ranked First in 2024 Dealer Group Study for Providing Quick and Easy Service Appointments
-
MedTech Innovator Asia Pacific Names APrevent Top 2024 Innovator in Grand Finals Competition
-
Nick Pollard Joins CAIA Association as Managing Director of Asia Pacific
-
Natera to Present New Signatera™ Colorectal Cancer Data at ESMO Showing 10X Advantage in Overall Survival
-
Teledyne FLIR Delivering Airborne Surveillance Systems to Japan Maritime Self-Defense Force Worth Up to $21 Million
-
Hoonigan Signs Asset Purchase Agreement to Divest 4 Wheel Parts’ Retail Stores and Associated E-Commerce Assets to ARB Corporation’s U.S. Affiliate, ORW USA
-
Hoonigan Announces Strategic Transaction to Strengthen Financial Foundation and Support Long-Term Growth
-
The 2024 Global Energy Transition Conference Kicks Off in Beijing's Future Science City
-
What’s New with Personio: Improved people insights, performance reviews and custom workflows drive impact for HR teams
-
Novel Computational Pathology-Based TROP2 Biomarker for Datopotamab Deruxtecan Was Predictive of Clinical Outcomes in Patients with Non-Small Cell Lung Cancer in TROPION-Lung01 Phase 3 Trial
-
Novel computational pathology-based TROP2 biomarker for datopotamab deruxtecan was predictive of clinical outcomes in patients with non-small cell lung cancer in TROPION-Lung01 Phase III trial
-
Summit (SMMT): Ivonescimab Monotherapy Reduced Risk of Disease Progression or Death by 49% Compared to Pembrolizumab Monotherapy in First-Line Treatment of Patients with PD-L1 Positive Advanced NSCLC
-
Coalition Announces Reinsurance Intermediary Coalition Re
-
Savara Announces New Data from Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Were Presented at the
-
Longboard Pharmaceuticals Announces Positive Interim Analysis Results from the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and
-
Day 2 of 11th Annual World Patient Safety, Science & Technology Summit Highlights Importance of Collaboration and Advanced Technologies
-
Aon and Marsh McLennan Call on (Re)insurance Industry to Aid Ukraine’s Resilience
-
Vista Outdoor’s Board of Directors Comments on Public Communication from MNC Capital
-
Boll & Branch’s Most Luxurious Fabric Debuts on the Runway at Prabal Gurung’s NYFW Show
-
Ifinatamab Deruxtecan Continues to Demonstrate Promising Objective Response Rates in Patients with Extensive-Stage Small Cell Lung Cancer in IDeate-Lung01 Phase 2 Trial
-
MNC Increases All-Cash Offer to $43 Per Share
-
Doctors Turning to Contrast Enhanced Ultrasound for Superior Results Without Realizing Reimbursement Is Also Favorable
-
Massachusetts Long-Term Care Bill Passes After Efforts by Elder Advocacy Groups
-
Assure Announces Amendment of Exchange Offer Relating to its Convertible Notes
-
Marcus & Millichap’s IPA Capital Markets Announces Strategic Hire of Industry Veteran in Dallas
-
NASA Postdoctoral Program seeks early career and senior scientists for prestigious fellowships at its locations across the U.S.
-
Gold Reserve Announces Update Regarding Special Meeting of Shareholders
-
Mastercard to Participate in Upcoming Investor Conference
-
UNITE HERE Local 11 Alert for Ashford Inc., Ashford Hospitality Trust and Braemar Hotels & Resorts Investors
-
ProFunds Announces Mutual Fund and ProFund VP Share Splits
-
AM Best Places Credit Ratings of Oregon Mutual Group Members Under Review With Negative Implications
-
Pharmaceutical Technology 2024 Excellence Awards Honor Botanical Solution Inc. (BSI) as Dual Category Award Winner
-
Stewart Announces Retirement of Group President Steven Lessack
-
Franklin Templeton Announces Reorganization of Western Asset Total Return ETF into Western Asset Bond ETF
